SONN
Sonnet BioTherapeutics
SONN
SONN
Delisted
SONN was delisted on the 2nd of December, 2025.
1 hedge funds and large institutions have $170K invested in Sonnet BioTherapeutics in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
1
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$687K | |
| 2 | -$441K | |
| 3 | -$340K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$283K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$258K |
